Phenotypic detection of metallo-beta-lactamase in clinical isolates of pseudomonas aeruginosa;Detección fenotípica de metalobetalactamasas en aislados clínicos de Pseudomonas aeruginosa

Kasmera

Volumn 40, Issue 2, 2012, Pages 113-121

  Perozo Mena, Armindo José ^a,b   Castellano González, Maribel Josefina ^a   Ling Toledo, Eliana ^b   Arraiz, Nailet ^a  

^a UNIVERSIDAD DEL ZULIA   (Venezuela)

^b Servicio Autónomo Hospital   (Venezuela)

Author keywords

Imipenem; MBL; Meropenem; Pseudomonas aeruginosa

Indexed keywords

EID: 84880618900     PISSN: 00755222     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Harris A, Torres-Viera C, Venkataraman L, DeGirolami P, Samore M, Carmeli Y. Epidemiology and Clinical Outcomes of Patients with Multiresistant Pseudomonas aeruginosa. Clinical Infectious Diseases 1999 May 1; 28(5):1128-33.
2. Pagniez G, Radice M. Prevalencia de metalo- α-lactamasas en Pseudomonas aeruginosa resistentes a carbapenemes en un Hospital Universitario de Buenos Aires. Revista Argentina de Microbiología 2006; 38(33): 37.
3. Sociedad Argentina de Bacteriología (SADEBAC). Consenso sobre criterio de ensayo, interpretación e Informe de las pruebas de sensibilidad en los BGNNF de importancia clínica. www aam org ar 2005.
4. Troillet N, Samore MH, Carmeli Y. Imipenem-Resistant Pseudomonas aeruginosa: Risk Factors and Antibiotic Susceptibility Patterns. Clinical Infectious Diseases 1997 Nov 1; 25(5):1094-8.
5. Sader HS, Jones RN, Gales AC, Silva JB, Pignatari AC. SENTRY antimicrobial surveillance program report: Latin American and brazilian results for 1997 through 2001. Brazilian Journal of Infectious Diseases 2004; 8:25-79.
6. Programa Venezolano de Vigilancia de la Resistencia Bacteriana a los Antimicrobianos. Etiología y Resistencia Bacteriana en Venezuela. 28-5-2011. Caracas, Venezuela. 28-5-2011.
7. Pineda M, Bonilla X, Perozo-Mena A. Boletín Sobre Etiología y Resistencia Bacteriana. 2008. Centro de Referencia Bacteriológica SAHUM.
8. The inhibitors of cell wall synthesis. In: Scholar E, Pratt W, editors. The Antimicrobial Drugs. Second Edition ed. New York: Oxford University Press; 2000. p. 51-80.
9. Suarez CJ, Kattan JN, Guzmán AM, Villegas MV. Mecanismos de resistencia a carbapenems en P. aeruginosa, Acinetobacter y Enterobacteriaceae y estrategias para suprevención y control. Infectio 2006; 10:85-93.
10. Shibata N, Doi Y, Yamane K, Yagi T, Kurokawa H, Shibayama K, et al. PCR Typing of Genetic Determinants for Metallo-α-Lactamases and Integrases Carried by Gram- Negative Bacteria Isolated in Japan, with Focus on the Class 3 Integron. J Clin Microbiol 2003 Dec 1; 41(12):5407-13.
11. Toleman MA, Biedenbach D, Bennett D, Jones RN, Walsh TR. Genetic characterization of a novel metallo-α-lactamase gene, blaIMP-13, harboured by a novel Tn5051- type transposon disseminating carbapenemase genes in Europe: report from the SENTRY worldwide antimicrobial surveillance programme. J Antimicrob Chemother 2003 Oct 1; 52(4):583-90.
12. Watanabe M, Iyobe S, Inoue M, Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1991 Jan 1; 35(1):147-51.
13. Yano H, Kuga A, Okamoto R, Kitasato H, Kobayashi T, Inoue M. Plasmid-Encoded Metallo-α-Lactamase (IMP-6) Conferring Resistance to Carbapenems, Especially Meropenem. Antimicrob Agents Chemother 2001 May 1; 45(5):1343-8.
14. Henry D, Speert D. Pseudomonas. In: Versalovic J, Carroll K, Funke G, Jorgensen J, Landry M, Warnock D, editors. Manual of Clinical Microbiology. 10th Edition ed. Washington DC: ASM Press; 2011. p. 677- 91.
15. Kiska D, Gillighan P. Pseudomonas. In: Murray P, Baron E, Jorgensen J, Landry M, Pfaller M, editors. Manual of Clinical Microbiology. 9th ed. Washington DC: ASM Press; 2007. p. 734-48.
16. Bauer AW, Kirby WM, Sherris JC, Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966 Apr; 45(4):493-6.
17. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-Second Informational Supplement. M100-S22[32]. 2012. Clinical and Laboratory Standards Institute.
18. Arakawa Y, Shibata N, Shibayama K, Kurokawa H, Yagi T, Fujiwara H, et al. Convenient Test for Screening Metallo-α -Lactamase-Producing Gram-Negative Bacteria by Using Thiol Compounds. J Clin Microbiol 2000 Jan 1; 38(1):40-3.
19. Hodge W, Ciak J, Tramont EC. Simple method for detection of penicillinaseproducing Neisseria gonorrhoeae. J Clin Microbiol 1978 Jan; 7(1):102-3.
20. Lee K, Lim YS, Yong D, Yum JH, Chong Y. Evaluation of the Hodge Test and the Imipenem-EDTA Double-Disk Synergy Test for Differentiating Metallo-α-Lactamase- -Producing Isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2003 Oct 1; 41(10):4623-9.
21. Crespo MP, Woodford N, Sinclair A, Kaufmann ME, Turton J, Glover J, et al. Outbreak of Carbapenem-Resistant Pseudomonas aeruginosa Producing VIM-8, a Novel Metallo-α-Lactamase, in a Tertiary Care Center in Cali, Colombia. J Clin Microbiol 2004 Nov 1; 42(11):5094-101.
22. Castanheira M, Bell JM, Turnidge JD, Mathai D, Jones RN. Carbapenem Resistance among Pseudomonas aeruginosa Strains from India: Evidence for Nationwide Endemicity of Multiple Metallo-α-Lactamase Clones (VIM-2, -5, -6, and -11 and the Newly Characterized VIM-18). Antimicrob Agents Chemother 2009 Mar; 53(3):1225-7.
23. Yan JJ, Hsueh PR, Ko WC, Luh KT, Tsai SH, Wu HM, et al. Metallo-α-Lactamases in Clinical Pseudomonas Isolates in Taiwan and Identification of VIM-3, a Novel Variant of the VIM-2 Enzyme. Antimicrob Agents Chemother 2001 Aug 1; 45(8):2224-8.
24. Galani I, Rekatsina PD, Hatzaki D, Plachouras D, Souli M, Giamarellou H. Evaluation of different laboratory tests for the detection of metallo-α-lactamase production in Enterobacteriaceae. J Antimicrob Chemother 2008 Mar 1; 61(3):548-53.
25. Guevara A, Gamboa A, Machado M, Vera M. Evaluación del ácido etilendiaminotetraacético y del mercaptoacético de sodio en la detección de metalo α-lactamasas en Pseudomonas aeruginosa mediante la técnica del disco combinado. Revista de la Sociedad Venezolana de Microbiología 2010; 30(1):11-7.
26. Lee K, Chong Y, Shin H, Kim Y, Yong D,Yum J. Modified Hodge and EDTA-disk synergy tests to screen metallo-α-lactamase- -producing strains of Pseudomonas and Acinetobacter species. Clinical Microbiology & Infection 2001; 7(2):88-91.
27. Li XZ, Nikaido H, Poole K. Role of mexAmexB- oprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1995 Sep 1; 39(9):1948-53.
28. Cabot G, Ocampo-Sosa AA, Tubau F, Macia MaD, Rodríguez C, Moya B, et al. Overexpression of AmpC and Efflux Pumps in Pseudomonas aeruginosa Isolates from Bloodstream Infections: Prevalence and Impact on Resistance in a Spanish Multicenter Study. Antimicrob Agents Chemother 2011 May 1; 55(5):1906-11.
29. Pitout JDD, Gregson DB, Poirel L, McClure JA, Le P, Church DL. Detection of Pseudomonas aeruginosa Producing Metallo-α- Lactamases in a Large Centralized Laboratory. J Clin Microbiol 2005 Jul 1; 43(7): 3129-35.
30. Buscher KH, Cullmann W, Dick W, Opferkuch W. Imipenem resistance in Pseudomonas aeruginosa resulting from diminished expression of an outer membrane protein. Antimicrob Agents Chemother 1987 May; 31(5):703-8.
31. Valenza G, Joseph B, Elias J, Claus H, Oesterlein A, Engelhardt K, et al. First Survey of Metallo-α-Lactamases in Clinical Isolates of Pseudomonas aeruginosa in a German University Hospital. Antimicrob Agents Chemother 2010 Aug 1; 54(8): 3493-7.